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Abstract.  During the active phase of myelination in 
myelin-deficient mutant mice (mid), myelin basic pro- 
tein (MBP) synthesis is defective and the myelin 
lamellae are uncompacted. In these mutants,  we found 
a  fast metabolism of the myelin-associated glycoprotein 
(MAG) and of sulfatides, and the presence of choles- 
terol esters and a degradation product of MAG, 
dMAG,  indicating that mid myelin was unstable.  The 
increased synthesis of MAG and Wolfgram protein, 
two proteins present in uncompacted myelin sheath 
and paranodal loops, was demonstrated by high levels 
of messengers.  Simultaneously, we found an accumula- 
tion of inclusion bodies, vacuoles, and rough en- 
doplasmic reticulum in mid oligodendrocytes. This 
material  was heavily immunostained  for MAG.  Fur- 
thermore,  the developmental change between the two 
molecular forms of MAG (p72MAG/p67MAG) was 
delayed in mM mice. In 85-d-old mid mice, the MBP 
content increased and myelin lamellae became better 
compacted. In these mutants,  dMAG was absent and 
MAG mRNAs were found in normal amounts.  Fur- 
thermore,  the fine structure of mid oligodendrocytes 
was normal and the MAG immunostaining  was similar 
to age-matched controls.  These results support a func- 
tional role for MBP in maintaining  the metabolic sta- 
bility and the compact structure of myelin.  Further- 
more,  in the absence of MBP and myelin compaction, 
the regulation of the synthesis of at least two mem- 
brane proteins related to myelin cannot proceed. 
I 
r~ the central nervous system of homozygous myelin-defi- 
cient mutant  mice (mid) 1 that  are affected by a severe 
myelin deficit (Doolittle and Schweikart,  1977), the ma- 
jor electron-dense line  of myelin  is absent and myelin ba- 
sic  protein  (MBP) concentrations  are drastically  reduced 
(Bourre et al., 1980, Ginalski-Winkelmann et al., 1982, Mat- 
thieu et al.,  1980a). MBP has been localized in the major 
dense line of compact central  and peripheral  myelin using 
immunocytochemical  techniques at the electron microscopic 
level (Omlin et al.,  1982), and it is generally accepted that 
MBP plays a key role in the fusion of the cytoplasmic faces 
of the  oligodendroglial  plasma  membrane  (Braun,  1984; 
Kirschner et al., 1984). Recently, we showed that when MBP 
concentration  in central  nervous  system myelin of mid mu- 
tants increases after the active phase of myelin deposition is 
completed in controls, the major electron-dense line appears 
concomitantly,  and  myelin  lamellae  are better compacted 
(Matthieu et al., 1984b). The mid mutation affects the synthe- 
sis ofMBP (Campagnoni  et al., 1984; Ginalski-Winkelmann 
et al.,  1983) whereas that of intrinsic  myelin proteins is not 
reduced (Matthieu  et al.,  1984a). 
1. Abbreviations used in this paper: MAG, myelin-associated glycoprotein; 
MBP,  myelin basic protein; mid, myelin-deficient. 
Shiverer mice phenotype is similar to mid (Dupouey et al., 
1979; Lachapelle et al.,  1980; Matthieu  et al.,  1981) and 
cross-breeding experiments indicate that both mutants are al- 
leles (Lachapelle  et al., 1980). Although  shiverer involves a 
deletion in the MBP gene (Kimura et al., 1985; Roach et al., 
1983), we found it unlikely that the mid mutation  involves a 
deletion in the coding region of the gene (Roch et al., 1986) 
as we were able to translate mid mRNA into MBP polypep- 
tides,  though  in reduced amounts,  with normal  molecular 
masses and immunoreactivity. 
The aim of this work was to investigate the stability of the 
myelin sheath in the absence of one of its major components, 
MBP, and to study the metabolism and regulation  of other 
myelin components that are not affected by the mid mutation. 
Preliminary  progress reports of this study have appeared 
in abstract  forms (Almazan  et al.,  1983; Matthieu  et al., 
1982;  Matthieu  and  Omlin,  1985; Omlin  and  Matthieu, 
1984). 
Materials and Methods 
Animals 
The mid rrfice and unaffected littermates used as controls are direct descen- 
dants of 15 pairs of mice from stock obtained from Dr. P. Doolittle (School 
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Figure  1.  Metabolism of MAG labeled in vivo with [3H]fucose. 
Normal  littermates  (solid circle)  and  mid  mutants  (open  circle) 
were injected at 21 d of age and killed after 16 h and 6, 10, and 15 d. 
The results given as specific radioactivity in dpm are the mean for 
three to five separate animals given with the standard error of the 
mean. Similar results were obtained in 25- and 60-d-old animals. 
of Agriculture, Purdue University, Lafayette,  IN) in 1979. From the start the 
stuck has been kept free from any out-cross and can be considered as inbred. 
FOr in vivo labelling, the mice were injected in each cerebral hemisphere, 
under ether anesthesia, with 10 gCi of L-[5,6-3H]fucose  (40-60 Ci/mmol) 
or Na235SO4 (10-1,000 mCi/mmol sulfur; New England Nuclear, Bostun, 
MA). The animals were killed by decapitation, the brains, optic nerves, and 
spinal cords  were  rapidly  removed,  rinsed in  ice-cold isotonic saline, 
weighed, and stored at  -80°C until myelin was isolated. For RNA isola- 
tion, the tissue was immediately frozen in liquid nitrogen after dissection 
and stored at  -80°C. 
Antisera 
Polycloual  rabbit  antisera  to  MBP, Wolfgram  protein,  and  myelin-associated 
glycoprotein  (MAG) have  been  prepared  in  our  laboratory  and  characterized 
(Matthieu  ct  al.,  1984a,  1986;  Waehneldt et  al.,  1985).  The antiserum  to 
the  glial  fibrillary  acidic  protein  was  a  generous  gift  of  Dr.  L.  F.  Eng  (Veter- 
ans Administration  Medical Center,  Palo  Alto,  CA). 
Protein and Lipid Analysis 
Frozen brains were homogenized in 0.32 M sucrose and myelin was isolated 
(Norton and Foduslo, 1973). Homogenate and myelin aliquots were removed 
and used for protein (Lowry et al., 1951), MAG (Johnson et al., 1982), and 
sulfatide (Kean,  1968) determination. Total  lipids from mM and control 
brains at 25 d of age were extracted (FOlch et al., 1957) and separated by 
thin layer chromatography to detect cholesterol esters (Kraus-Ruppert et al., 
1972). 
[35S]Sulfatides  were  counted  for  radioactivity  by  liquid  scintillation 
spectrometry. The incorporation of 3H into MAG was measured after sepa- 
ration by SDS-PAGE as reported in detail elsewhere (Quarles et al., 1985). 
Delipidated myelin fractions or nervous tissue homogenate samples were 
solubilized in SDS and separated by electrophoresis  on polyacrylamide disc 
or slab gels (Laemmli,  1970). Proteins separated by electrophoresis were 
transferred electrophoretically to nitrocellulose sheets (Towbin et al., 1979). 
The nitrocellulose sheets were incubated successively with preimmune sera 
or antisera to MAG, then with t25I-protein A (2-10 Ci/g, New England Nu- 
clear, Boston, MA) and exposed to Kodak X-Omat AR-5 film at  -80°C. 
Autoradiographs were scanned on a Vitatron TLD  100 densitometer mea- 
suring the transmitted light. Molecular masses of proteins were estimated 
from a graph of  the logarithm of  the molecular masses of standard molecules 
versus their migration distances on the gels. 
Isolation of mRNA and Size Fractionation 
Total RNA was prepared from mouse brains by phenolchloroform  extraction 
and ethanol precipitation. It was then loaded onto an oligo-dT cellulose 
column  in  order  to  select the  poly(A)  +  RNAs.  In  some experiments, 
mRNAs were size-fractionated by centrifugation on a  sucrose gradient. 
These procedures are described in detail by Maniatis et al.  (1982). 
In Vitro Translation and Immunoprecipitation 
In vitro translation of the poly(A)  + RNAs was performed in a  nuclease- 
treated message-dependent rabbit reticulocyte lysate (Amersham Interna- 
tional, Amersham, England) in the presence of L-[35S]methionine  (1,300 
Ci/mmol, Amersham International). We used 2 I.tg of mRNA with 14 ~tl ly- 
sate and 20 ~tCi L-[35S]methionine in a total reaction volume of 20 I~1. Pro- 
tein synthesis was carried out for 1 h at 30°C. After a chase (2 ~tl of 10 mM 
cold L-methionine, 30 rain at 30°C), the level of protein synthesis was esti- 
mated by TCA precipitation of 2-~tl aliquots on glass fiber filters followed 
by liquid scintillation counting. The rest of each sample was then placed 
in boiling water for 5 min in the presence of 4% SDS, and diluted with 500 
~tl RIPA buffer (1% Triton X-100, 150 mM NaCI, 5 mM EDTA, 50 mM Tris 
HCI, pH 7.4).  Equal amounts of synthesized proteins, as determined by 
TCA precipitation, were immunoprecipitated as follows: (a) preclearing for 
2 h at room temperature with 30 ttl of 10%  Staphylococcus aureus cells 
(Calbiochem-Behring Corp., San Diego, CA), with stirring; (b) immuno- 
reaction overnight at 4°C with 10 ~tl antiserum; and (c) immunoadsorption 
for 2 h at room temperature with 30 Ixl of 10% S. aureus cells, with stirring. 
The cells carrying immune complexes were washed three times with RIPA 
buffer before solubilization at 95°C for 5 rain in 55 ~tl of sample buffer (150 
raM Tris HCI, pH 6.8, 6% SDS, 6 mM EDTA,  0.03%  bromophenol blue, 
30% glycerol, 1% 13-mercaptoethanol).  The immunoprecipitated translation 
products were then separated by SDS-PAGE (8-15 %) according to Laemmli 
(1970). After Coomassie Blue staining, the gel was treated with Na-salicylate 
and exposed for 18 d at  -80°C on a Kodak film (X-Omat SO-282).  The 
flms were scanned on a densitumeter for quantitative estimation. 
Morphology 
For light and electron microscopic investigations, mutant mice and un- 
affected littermates were studied at different stages of postnatal develop- 
ment: 7,  15, 30, 52, and 85 d after birth. For each age and group, four to 
six animals were fixed by intracardiac perfusion with a fixative containing 
0.5 % glutaraldehyde and 1.5 % paraformaldehyde in 0.1 M phosphate buffer 
at pH 7.6. Optic nerves, cervical spinal cord, and trigeminal nerves were 
removed and cut into smaller pieces, which were postfxed in 2 % osmium 
tetroxide for 2 h at room temperature and 1 h at 4°C. The samples were 
then dehydrated in ethanol and embedded in Epon. Thin sections were cut 
with a diamond knife on an Ultracut microtome (Reichert Scientific Instru- 
ments, Buffalo, NY), mounted on Formvar-coated slot grids, and examined 
with a Zeiss M10 electron microscope. 
Immunocytochemistry 
The procedure that we used allows the characterization of the fine structure 
of cells immunostained at the light microscopic level (Trapp and Quarles, 
1982). Briefly,  1-lxm semi-thin and thin sections were cut alternately.  The 
1-~tm sections were deplasticized with a solution of sodium ethoxide/abso- 
lute ethanol followed  by 0.03 % hydrogen peroxide treatment. The tissue was 
then immunostained for MAG (1:250)  by the peroxidase-antiperoxidase 
technique (Sternberger et al.,  1970). Immunostained sections were pho- 
tographed and directly compared with electron mierographs showing the 
same area from adjacent thin sections. 
Results 
Turnover of  MAG and Sulfatides 
The turnover rate of [3H]fucose was measured in mid and 
control mice, 16 h and 6,  12, and 15 d after the intracerebral 
injection.  In 21- and 60-d-old animals,  [3H]fucose in total 
brain homogenates showed a half-life of '~12 d for both con- 
trol and mid mice. In control myelin the specific radioactivity 
of [3H]fucose in MAG remained practically constant during 
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Figure 2.  Metabolism of sulfatides labeled in vivo with [35S]sul- 
fate. Normal littermates (solid circle) and mid mutants (open circle) 
were injected at 21 d of  age and killed after 16 h and 6, 12, and 15 d. 
The results expressed as specific radioactivity in dpm are the mean 
for three to four separate animals given with the standard error of 
the mean. 
the study period (Fig. 1). In mid myelin, the rate of incorpo- 
ration of [3H]fucose into MAG was four times higher than 
in controls and the turnover of MAG was very fast, with a 
half-life of ~10 d in 21- and 60-d-old mutants (Fig.  1). 
The turnover of 35S-labeled material in total brain homog- 
enates after intracerebral injection of [35S]sodium sulfate at 
21 and 60 d of age was similar for mid and control mice. In 
control myelin, [35S]sulfatide specific radioactivity remained 
stable during the study period (Fig. 2). Control experiments 
showed that after separation on one-dimensional thin layer 
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Figure 3.  Densitometric scans of MAG immunoblots from 12.5% 
polyacrylamide slab gels. Direction of migration from the left to the 
right.  Each well contained 50 Ixg of myelin protein.  Autoradio- 
graphs were exposed for 5 h. CO, control. 
chromatography, 98 % of the total radioactive sulfate present 
in myelin lipids was recovered in the sulfatide spots. In mid 
myelin 16 h after the injection, the specific radioactivity of 
[35S]sulfatides was two and a half to four times higher than 
in controls. The turnover rate of [35S]sulfatides in mid my- 
elin was very fast, with a half-life of ~10 days (Fig. 2). 
Characterization of  MAG by Electrophoretic 
Analysis and lmmunoblotting 
MAG in the spinal cord and optic nerves of control and mid 
mice was  studied by electrophoresis and immunoblotting. 
The concentration of MAG present in the protein extract of 
total homogenates was reduced in mid mutants and decreased 
with age (Fig. 3). By radioimmunoassay, at 25 d of age the 
concentration of MAG in total brain homogenate and puri- 
fied myelin of  mid mutants was 38 and 59% of control values, 
respectively  (Matthieu,  J.-M.,  D.  Johnson,  and  R.  H. 
Quarles, manuscript in preparation). 
The apparent molecular mass of MAG was  115,000 D  in 
both control and mid mice. In mid mice, a polypeptide 10,000 
D smaller than MAG was identified between 15 and 40 d, but 
was  absent  from  85-d-old  mutants  (Fig,  3).  This  lower 
molecular mass component reacted with two different an- 
tisera to MAG and it co-migrated with the degradation prod- 
uct of MAG (Matthieu et al.,  1977), called dMAG by Sato 
et al.  (1982,  1984). 
In Vitro Translation of  MBP, MAG, 
and Wolfgram Protein 
Poly(A)  + RNAs were prepared from control and mid brains 
at different ages between 18 and 85 d of age and translated 
in  vitro  in  a  nuclease-treated  message-dependent  rabbit 
reticulocyte lysate  in  the  presence  of L-[asS]methionine. 
The translation products were immunoprecipitated with an- 
tisera to MBP,  MAG,  or Wolfgram protein,  separated by 
electrophoresis, visualized by fluorography, and measured 
by densitometric scanning of fluorographs. The immunopre- 
-  cipitated translation products were identified as MBP, MAG, 
or Wolfgram protein by the following criteria: (a) they re- 
acted specifically with the relevant antiserum, (b) they were 
not precipitated by preimmune sera, and (c) they migrated 
with electrophoretic mobilities identical to those of authentic 
L  standards  (data  not  shown).  Furthermore,  in  the  case of 
MBP,  for which  we have the purified antigen,  the bands 
could be displaced by adding an excess of cold antigen to the 
immunoprecipitation mixture. 
L  At 18 d of age, the amount of translatable messenger for 
:  MBP was drastically reduced in mid brains when compared 
with normal littermates (Fig. 4). In contrast, the amounts of 
translatable messenger for MAG and Wolfgram protein were 
-  increased in mid brains  in comparison with normal litter- 
:~  mates (Fig. 4). 
MAG translation products were analyzed in mid and con- 
trol brains at different ages between  18 and 85 d  (Fig.  5). 
MAG  was  present  in  two  different  forms.  The  apparent 
molecular masses  of the  unprocessed polypeptide chains 
were 72,000 and 67,000 D,  respectively (Frail and Braun, 
1984). Therefore, we shall refer to these translation products 
as  p72MAG  and  p67MAG.  Both  p72MAG  and  p67MAG 
mRNAs exhibited a sedimentation coefficient of 23S (as de- 
termined by migration on a sucrose gradient), indicating that 
they have similar sizes (data not shown).  During develop- 
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Figure 4.  Densitometric  scans of fluorograms  of immunoprecipi- 
tated MBP, MAG, and Wolfgram protein (WP) polypeptides  in nor- 
mal littermate  (CO, control)  and mid mouse brains at 18 d of age. 
We translated  2 ~tg mRNA. For a given phenotype (CO or mid), 
it is not possible to compare the levels of synthesis between the three 
proteins,  nor to make a direct correlation with the amounts of their 
mRNAs, because these messengers  can have different translational 
efliciencies,  and the number of methionine  residues  per molecule 
is not the same for the three proteins. 
ment, the amount of translatable p72MAG mRNA decreased 
in control brains, whereas p67MAG mRNA, which was first 
detected at 25 d, reached a peak at '~40 d and then decreased 
(Fig. 5). In mid brains, the amount of p72MAG mRNA also 
decreased during development but the p67MAG mRNA re- 
mained  at a  constant level.  Therefore,  the  ratio  p72MAG/ 
p67MAG changed during development. In control mice, the 
p72MAG was the predominant form of MAG at 18 and 25 d, 
whereas p67MAG became the major component at 40 d (Fig. 
5). This shift toward the lower molecular form of MAG was 
delayed in mid brains. It occurred before 40 d in controls and 
after 50 d in mid mice (Fig. 5). These in vitro translation ex- 
periments were carried out independently in both laborato- 
ries with similar  results. 
Electron Microscopy and MAG Iramunostaining 
During active myelination (7,  15, and 25 d  after birth),  mM 
mutants  showed  morphologically  and  immunocytochemi- 
cally altered  oligodendrocytes.  Approximately  70-80%  of 
the myelin-forming glial cells were characterized by the fol- 
lowing  abnormalities  (Figs.  6  A  and  7  A):  (a)  dark cyto- 
plasm,  (b)  accumulations  of  electron-lucent  membrane- 
bound profiles of variable size, (c) atypical Golgi apparatus 
with dilated cisternae, and (d) abnormal endoplasmic reticu- 
lum  (Figs.  6  B  and  7  A),  which  was  extended  and  often 
showed a whorl-like structure.  However, it is interesting to 
note that the number of necrotic cells was not changed in mid 
Figure 5. Fluorograms and densitometric  scans of immunoprecipitated  MAG polypeptides synthesized  in vitro from mRNA isolated from 
normal littermate (controls) or mid mutant brains between  15 and 85 d. We translated  in vitro 2 Ixg mRNA, immunoprecipitated  the transla- 
tion products with an antiserum to MAG, and analyzed them by electrophoresis  and fluorography. (A) Fluorogram showing p72MAG and 
p67MAG from control brains at 18, 25, 40, and 50 d of age (lane 1-4); O, origin of migration.  A high molecular mass (141-kD) peptide 
was also identified, depending on the antiserum used. The molecular mass and the intensity of labeling of this peptide remained unchanged 
through development  and served as an internal  standard.  (B and C) Densitometric scans of fluorograms  of immunoprecipitated  p72MAG 
(open arrowhead) and p67MAG (solid arrowhead). The amounts  of synthesized  proteins,  as determined by TCA immunoprecipitation, 
were equalized between age groups within each phenotype, controls (B) and mid (C). It is therefore possible to compare the level of MAG 
synthesis between  ages within  each phenotype only. It is not possible  to compare the intensity  of the MAG signals  in terms  of amounts 
of mRNA because: (a) as mentioned in the Discussion,  these two polypeptides possibly contain different numbers of methionine residues, 
and (b) the two different messages may have different translational  efficiencies. For a given protein, however, the amount of immunoprecipi- 
tated protein  correlates well with the level of its own mRNA. 
The Journal of Cell Biology, Volume  103, 1986  2676 Figure 6. Electron micrographs of optic nerves of mid mutant mice at 15 d after birth. (A) Overall appearance of an abnormal oligodendro- 
cyte (OC), showing a light nucleus and a relatively dark cytoplasm. Note the presence of normal mitochondria, endoplasmic reticulum 
(large open arrow), and microtubules (small arrows); the rough endoplasmic reticulum is often in close apposition to the mitochondria. 
The large solid arrow points at membrane-bound electron-lucent vesicles, which also appear in clusters. Typical features of an oligodendro- 
cyte can be identified  in the figure: light nucleus, dark cytoplasm-containing microtubules, and absence of gliofilaments. Well-defined  Golgi 
apparatus was absent. Bar, 2 Ixm. (B) High magnification electron micrograph, which shows part of an oligodendrocyte (OC), an astrocytic 
process containing gliofilaments (f), naked axons (a/), and axons (a2) that are ensheathed by an uncompacted oligodendrocyte process. 
This oligodendrocyte shows a complex of smooth and rough endoplasmic reticulum. A sort of transition from rough to smooth endoplasmic 
reticulum is indicated by a curbed arrow.  Microtubules  in cross section are present (small arrow). Bar,  0.5  gm. 
tissue when compared with the age-matched controls, which 
showed normal oligodendrocytes with their typical morpho- 
logical  characteristics.  Furthermore,  gliosis  and  macro- 
phage infiltration was not present in mid tissue,  confirming 
previous observations made in shiverer, the mid allele (Bird 
et al.,  1978). 
Adjacent semi-thin sections of mid (Fig.  7 B) and control 
tissue (Fig.  7  C) of 15-d-old animals were immunostained. 
The optic nerve of the mutants showed large accumulations 
of immunoprecipitates  within the cytoplasm of these oligo- 
dendrocytes (Fig.  7 B, right and left arrows).  The pattern of 
immunostaining  corresponded  well  with  the  areas  on  the 
electron  micrographs  (Fig.  7  A),  in  which  there  were 
accumulations  of membrane-bound  profiles  and  abnormal 
formations  of the  endoplasmic  reticulum.  MAG-immuno- 
stained ceils were clearly identified by electron microscopy 
Matthieu et al. Instability  and Metabolism in Myelin-deficient  Mice  2677 The Journal of Cell Biology, Volume  103, 1986  2678 Figure 8.  Electron- and light (inset) micrographs of adjacent  thin and semi-thin  sections  of the cervical spinal cord from a  15-d-old mid. 
The electron micrograph shows an axon (X) that is surrounded by an oligodendrocyte process forming loose myelin.  The semi-thin section 
is immunostained  for MAG. Accumulation of immunoprecipitates  are localized between these loose, uncompacted myelin membranes.  Bar, 
2  lim (inset,  4  lim). 
as oligodendrocytes. Moreover, as reported previously (Mat- 
thieu and Omlin,  1984),  these cells were negative for glial 
fibrillary acidic protein antiserum, a marker of  astrocytes. At 
this stage, many axons were ensheathed by oligodendrocyte 
processes, which formed a loose sheath.  Within these loops 
many  longitudinal  profiles  of microtubules  and  vesicular 
structures were present (Fig. 8). The adjacent semi-thin sec- 
tion immunostained for MAG revealed intense immunopre- 
cipitates, which corresponded to loose myelin (Fig. 8, inset). 
At 85 d after birth, the myelination of  optic nerves and cer- 
vical spinal cord in normal controls was complete. Immuno- 
stained sections of this tissue showed oligodendrocytes with 
granular, dot-like immunoreaction product for MAG (Fig. 7 
E, arrow) similar to that of premyelinating stages (e.g., Fig. 
7 C, arrow). Furthermore, a narrow ring of immunostaining 
was visible around axons. The age-matched mM (Fig. 7 D) 
showed a very similar pattern of immunostaining for MAG 
to that of the controls.  Small granules  of reaction product 
Figure Z  Electron (A) and light micrographs (B-E) of optic nerves (A-C) and spinal cord (D and E) of mM mutant mice at 15 d (A and 
B) and 85 d (D) after birth, and age-matched control animals (C and E ). All light micrographs of 1-11m thin sections (B-E) show immuno- 
staining for MAG. (A) This row of interfascicular  glia is composed of five cells (1-5), which show abnormal formations of rough endoplas- 
mic reticulum (left arrow).  Accumulations of membrane-bound vacuoles are also present in the cytoplasm of these oligodendrocytes  (right 
arrow, cells 3-5). Bar, 5 gtm. (B) l-gtm section immunostained  for MAC; adjacent to the thin section of  A. The same row of interfascicular 
glia (cells 1-5) is shown. Accumulations of intense immunoprecipitates  (arrows) within the cytoplasm of oligodendrocytes (3-5) match 
with the abnormal structures  described in A. Bar,  10 Ixm. (C) Immunostained interfascicular  glia cell row of a control optic nerve.  The 
immunoprecipitates  (arrow) within the cytoplasm of these myelinating oligodendrocytes  appear dot-like and were associated with normally 
formed Golgi regions in corresponding electron micrographs. Bar, 10 ~tm. (D and E) 1-~tm  thick sections of mid (D) and control (E) cervical 
spinal cord of 85 d-old animals immunostained  for MAG. In the mid tissue the staining is irregular but the intense accumulations of reaction 
product observed in young mice are no longer present.  The pattern of staining  in oligodendrocyte cell bodies is similar to age-matched 
controls (arrows).  Bar,  10 gtm. 
Matthieu et al. Instability and Metabolism in Myelin-deficient Mice  2679 were located in the cytoplasm of the oligodendrocytes (Fig. 
7 D, arrow). Intense accumulations of immunoprecipitates in 
the oligodendrocytes were very rare. Furthermore, most of 
the axons were surrounded by a ring of immunoprecipitates 
comparable to that of age-matched controls.  However,  in 
some axons the labeling did not surround the whole circum- 
ference; this corresponded to the electron microscopic ap- 
pearance of axons, which were surrounded by an incomplete 
myelin sheath (Matthieu et al.,  1984b). 
Discussion 
Instability of  Myelin in the Absence of  MBP 
In the central nervous system of mM mice during the active 
phase of myelin formation almost no MBP can be detected 
(Bourre et al.,  1980; Jacque et al.,  1983; Matthieu et al., 
1980a,  1984b). The axons are loosely wrapped by mem- 
branes that only fuse at the extracellular sites forming the in- 
traperiod line, and the major dense line that normally con- 
tains  MBP  (Golds and Braun,  1976; Omlin et al.,  1982; 
Poduslo and Braun,  1975) is missing (Bourre et al.,  1980; 
Matthieu et al.,  1980, 1984b). At a  time when the active 
phase of myelin deposition is already completed in controls, 
the MBP concentration continues to increase in mM myelin 
with the concomitant appearance of the major electron-dense 
line and better compaction of the myelin lamellae (Matthieu 
et al., 1984b). Since MBP seems to play a key role in the for- 
mation of the compact structure of central nervous system 
myelin, one could speculate that it is involved in the stability 
of the  multilayered structure.  Several  pieces  of evidence 
demonstrate that the uncompacted myelin lamellae in the mid 
brain are unstable. (a) The presence of increased levels of 
cholesterol esters in the brain of 25-d-old mid mice shows 
that myelin is degraded as in demyelinating disorders (Nor- 
ton and Cammer,  1984). (b) In normal conditions, myelin 
proteins and lipids have extremely slow turnover rates (Ben- 
jamins and Smith, 1984). This was confirmed in the present 
study for MAG and sulfatides in myelin of control mice. In 
contrast,  in mid myelin,  both  MAG and  sulfatides were 
turned over very rapidly.  (c) The degradation form of MAG 
(Matthieu et al., 1977), dMAG (Sato et al., 1982, 1984) was 
found in mid optic nerve and spinal cord when myelin is un- 
compacted and  its  MBP  content drastically reduced.  As 
reported previously (Bird et al., 1978), there was no morpho- 
logical sign of massive demyelination: no phagocytosed my- 
elin profiles, no macrophage infiltration or gliosis. This indi- 
cates a subtle myelin destruction only detected by the fast 
turnover rate of myelin components and by the presence of 
dMAG and cholesterol esters. At 85 d of age when the major 
dense line was present and the concentration of MBP in- 
creased, no dMAG could be found. 
Recent evidence indicates that MBP is synthesized in mid 
at a very low but constant level during development (Roch, 
J.-M., manuscript in preparation). During the active phase 
of myelin formation, large amounts of membranes are pro- 
duced by the oligodendrocyte, but the very low amounts of 
MBP are insufficient to compact the multilayered structure 
that then undergoes degradation. After the peak of rapid my- 
elination is terminated, the low amounts of MBP synthesized 
are adequate to form the major electron-dense line and the 
thin myelin sheath wrapped around the axons is better com- 
pacted (Matthieu and Omlin, 1984; Matthieu et al., 1984b). 
In these adult mutants, dMAG is absent. This is the first di- 
rect demonstration of the role of MBP for the compaction 
and stability of myelin in the central nervous system. 
Metabolism of  Oligodendrocytes 
At the electron microscopic level, the oligodendrocytes in 
young mid mice showed an accumulation of  vacuolar profiles 
of different sizes, numerous microtubules, prominent Golgi 
complexes with dilated cisternae, and abnormal formation 
of the rough endoplasmic reticulum. Similar findings were 
reported by others in mid (Shen et al., 1985) and in shiverer 
mice (Inoue et al., 1983; Privat et al., 1979). This indicates 
an accumulation of various materials, resulting in degrada- 
tion of these organelles and the formation of a lysosomal sys- 
tem for disposing of them. Once the concentration of MBP 
increases in told myelin and the multilayered sheath becomes 
better compacted, such abnormal oligodendrocytes are rare 
(Matthieu and Omlin,  1984). 
Previous work from this laboratory has shown that the de- 
velopmental pattern of myelin lipid-synthesizing enzymes 
and the lipid composition of myelin is normal in mM mutants 
(Matthieu, J.-i., manuscript in preparation). Furthermore, 
the in vitro synthesis of two intrinsic myelin proteins present 
in compact myelin is not impaired in mid nerves (Matthieu 
et al., 1984). Therefore, the genetic program for myelin for- 
mation appears to be intact in the mM mutation and the my- 
elin deficit seems to be secondary to the lack of MBP, which, 
according to our findings, appears to be responsible for the 
stability of the myelin sheath. 
Recent work indicates that the timing of myelin gene ex- 
pression  is  independent of continuous neuronal influence 
(Zeller et al., 1985) and that oligodendrocytes in culture can 
form compact myelin in the absence of neurons (Bradel and 
Prince,  1983; Guentert-Lauber et al., 1985). What remains 
unknown is the mechanism that turns down the synthesis of 
myelin components in vivo when the period of myelin thick- 
ening is completed. The present study seems to give a clue 
to this question. This mechanism could involve the discon- 
tinuation of an activating factor or the appearance of an in- 
hibiting factor.  In any case, this mechanism is likely to act 
on gene transcription, since the amounts of MBP mRNA and 
MAG mRNA decrease during development of normal mice 
(Frail and Braun, 1984; Zeller et al.,  1984). In mid brains, 
the high levels of messenger for MAG and the Wolfgram pro- 
tein, two proteins enriched in uncompacted myelin sheath 
and paranodal loops (Matthieu et al., 1973), indicate that this 
putative regulation signal did not reach the oligodendrocyte 
transcription apparatus. This hypothesis is supported by ob- 
servations  in  other  dysmyelinating mutants and does  not 
seem to be restricted to a defect of MBP synthesis. For exam- 
ple,  inappropriately high levels  of MBP  gene expression 
were reported in jimpy mice (Carnow et al.,  1984), where 
the mutation affects the proteolipid protein structural gene 
(Dautigny et al., 1986; Gardinier et al., 1986). Furthermore, 
in a canine dysmyelinating  mutant dog (Inuzuka et al., 1986), 
abnormalities were observed in oligodendrocytes similar to 
the ones we report here with accumulation of MAG. All of 
these mutants seem to be affected by a secondary defect in 
the regulation of myelin protein synthesis. 
In mid mutants, the synthesis of at least two myelin-related 
components, MAG and the Wolfgram protein, would avoid 
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is likely that the synthesis of all myelin components are not 
under the same regulatory mechanism.  The developmental 
shift of MAG towards a slightly lower molecular mass ob- 
served in rodents (Matthieu  et al., 1974, 1975; Quarles et al., 
1973) and the differences in the expression of its two molecu- 
lar  forms observed by  Frail and  Braun  (1984)  and in this 
study,  support this view. Although p72MAG  and p67MAG 
differ only by an additional sequence in the high molecular 
mass  form (Frail  and  Braun,  1984),  it is not  known how 
many,  if any, methionine  residues this  sequence contains. 
Clearly, the presence of methionine residues in this sequence 
would influence the estimation of the  relative  amounts of 
these two forms of MAG,  with p72MAG  being  somewhat 
overestimated relative to p67MAG.  This makes determina- 
tion  of the  precise  timing  of the  switch between the  two 
forms, in the normal mouse, difficult. However, the fact re- 
mains  that  this  switch  is  significantly  delayed  in the  mid 
mouse. The prolonged predominance of the large form in the 
mid mutants could indicate a preferential  localization in the 
uncompacted myelin sheath.  In the shiverer mutant,  which 
is allelic with the mid mouse (Lachapelle et al.,  1980),  the 
ratio between the two forms of MAG studied in immature and 
adult animals was normal (Frail and Braun,  1985). Neverthe- 
less, a delayed change in the ratio p72MAG/p67MAG during 
shiverer development could have remained unnoticed, since 
only D-d-old and adult mice were investigated.  The function 
of one of the Wolfgram proteins that is identical to the myelin 
enzyme 2',3'-cyclic nucleotide 3'-phosphohydrolase (Drum- 
mond and Dean, 1980; Sprinkle et al., 1980),  as well as that 
of MAG, is still unknown. Nevertheless, it is of interest that 
large amounts  of the  former (Matthieu  et al.,  1984b)  and 
heavy  immunostaining  of the latter  (Matthieu  and  Omlin, 
1985) are present in uncompacted myelin sheath from 25-d- 
old mid mice. This implies that these two components have 
an important  function in the initial  stages  of myelination, 
and,  as suggested by Frail and Braun  (1984),  this function 
would no longer be necessary in the latter stages of myelina- 
tion, or may even become incompatible, as indicated by our 
present data in the mid mutants. 
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